ArticleMalignancy Risk Among Psoriasis Patients Treated With Interleukin Inhibitors: A Retrospective Matched-Cohort StudyAuthor:Anuj Kunadia, MDPublish date: February 25, 2026Psoriasis is a chronic immune-mediated inflammatory skin disease that affects approximately 2% to 3% of the global population and an estimated 7.5 ...Read More
